ARTELO BIOSCIENCES, INC.
SOLANA BEACH, CA · CIK 0001621221 · Biotech · Public
Small molecule therapeutics that modulate lipid-signaling pathways for cancer treatment
artelobio.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $33M
- 15 Form D · Apr 2026
- 6 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 3 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $850,786 | |
| Private capital raised | Form D · SEC | $525,824 | |
| Private capital raised· 1 of 2 same day | Form D · SEC | $4,192,990 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $857,430 | |
| Private capital raised | Form D · SEC | $55,000 | |
| Private capital raised | Form D · SEC | $96,972 | |
| Private capital raised | Form D · SEC | $1,425,000 | |
| Private capital raised | Form D · SEC | $9,475,000 | |
| Private capital raised | Form D · SEC | $3,718,121 | |
| Private capital raised | Form D · SEC | $500,000 | |
| Private capital raised· 1 of 3 same day | Form D · SEC | $237,300 | |
| Private capital raised· 2 of 3 same day | Form D · SEC | $113,000 | |
| Private capital raised· 3 of 3 same day | Form D · SEC | $315,000 | |
| Private capital raised | Form D · SEC | $10,996,903 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2498 | DUET BIOSYSTEMS, INC | — | — |
| 2499 | Trex Bio | — | — |
| 2500 | Emergent BioSolutions | — | $48M |
| 2501 | ARTELO BIOSCIENCES, INC. | — | $33M |
| 2502 | Celmatix Inc. | — | $20M |
| 2503 | Exciva | — | — |
| 2504 | GYRE THERAPEUTICS, INC. | — | $5.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- John BeckDirector
- Douglas BlayneyDirector
- R. EmanueleDirector
- Georgia ErbezDirector
- Tamara FavoritoDirector
- Gregory GorgasDirector · Executive Officer
- Steven KellyDirector
- Connie MatsuiDirector
- Peter O'BrienDirector · Executive Officer
- Gregory ReyesDirector
- Tamara SeymourDirector
- Mark SpringDirector · Executive Officer
Patents
- Solid Forms Of Cannabidiol And Uses Thereofgranted
- Solid Forms Of Cannabidiol And Uses Thereofgranted
- New Solid Forms Of Cannabidiol And Uses Thereofgranted
- New Solid Forms Of Cannabidiol And Uses Thereofapplication
- Increased Bioavailability And Efficacy Of Cbd Via Coadministration With Tetramethylpyrazineapplication
- New Solid Forms Of Cannabidiol And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.